# Advisor Review - GPT-5.2

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5.2
**Paper:** paper.pdf
**Timestamp:** 2026-03-05T11:19:21.140221
**Route:** OpenRouter + LaTeX
**Paper Hash:** 370440a3fa7758a8
**Tokens:** 17260 in / 1042 out
**Response SHA256:** 1ca1075b5e23d44a

---

I checked the draft strictly for **fatal errors** in (1) data–design alignment, (2) regression sanity, (3) completeness, and (4) internal consistency. I did **not** evaluate novelty, writing, or “interestingness.”

## 1) Data–Design Alignment (critical)

- **Treatment timing vs. data coverage:** Treatment is **September 2023**; collision data are stated to cover **Jan 2019–Dec 2024** (Data section + appendix). This is aligned (post-period exists through Dec 2024).
- **Post-treatment observations:** Yes. Post period is **Sep 2023–Dec 2024** (16 months), and the panel is explicitly 72 months total (2019–2024).
- **Treatment definition consistency:** Treatment indicator is consistently defined as **Welsh × Post (Sep 2023+)** in Data/Strategy/Tables. No conflicting “first treated year” definitions.

No fatal data/design misalignment found.

## 2) Regression Sanity (critical)

I scanned the regression tables for impossible values / clearly broken outputs:

- **Table 2 (Main collisions):** Coefficients and SEs are in plausible ranges for log outcomes and counts. No NA/Inf/NaN. R² not reported (not required by your rules). N reported.
- **Table 3 (Robustness/placebos):** All coefficients and SEs are plausible; no extreme SE-to-coefficient ratios suggesting a broken regression.
- **Table 4 (Property):** Coefficients (~0.04) and SEs (~0.006) are plausible for log prices with millions of observations.

No fatal regression-output issues found (no impossible statistics, no enormous/absurd coefficients or SEs, no missing SEs).

## 3) Completeness (critical)

- No “TBD/TODO/XXX/NA” placeholders in tables.
- Regression tables report **Observations (N)** and **standard errors**.
- Analyses described in text are reflected in at least one table/figure reference (main DiD, placebos, property regression). Nothing is described as done but completely missing from results tables/figures.

No fatal completeness problems found.

## 4) Internal Consistency (critical)

- **Numbers match across text and tables:**  
  - Main log effect **−0.227** with implied **−20.3%** and **p = 0.031** matches Table 2 and the abstract.  
  - RI p-value **0.002** matches Table 2 / Table 3 and text.  
  - Property effect **4.4%** matches Table 4 and abstract.
- **Timing consistency:** Pre period ends **Aug 2023**; post starts **Sep 2023** consistently across summary stats, model definition, and figures’ notes.

No fatal internal inconsistencies found.

ADVISOR VERDICT: PASS